查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493329

美国脸部注射剂市场规模、份额和趋势分析报告：按产品、按应用、按最终用途、按地区和细分市场预测，2024-2030 年

U.S. Facial Injectable Market Size, Share & Trends Analysis Report By Product (Botulinum Toxin Type A, HA), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国脸部注射剂市场成长与趋势：

根据Grand View Research, Inc.的最新报告，预计2030年美国脸部注射剂市场将达到80.2亿美元，2024年至2030年的复合年增长率为11.1%。

对美容治疗的接受度不断提高以及老年人口的增加是推动市场成长的主要因素。

美国日益老化的人口正在增加对微创外科手术开发的需求。脸部注射剂提供了一些整容手术的替代方案。此外，这些手术还具有多种好处，例如减少疼痛、减少创伤、减少出血和恢復更快。此外，越来越多的市场参与者专注于开拓低过敏风险需求的专业解决方案，这对市场成长做出了重大贡献。

由于对脸部外观的日益关注，人们对整容手术的认识不断提高，这进一步推动了市场的成长。此外，脸部注射剂的可用性可以满足不同患者的需求，这增加了不同年龄层的需求，这取决于患者的需求。例如，根据美国整形外科医师协会发布的2022年整形外科统计报告，2022年30-39岁和40-54岁年龄层的神经调节剂注射手术数量较2019年分别增加了70%和74%。同样，到2022年，30-39岁和40-54岁年龄层的HA填充手术数量将比2019年同时增加69%和70%。因此，不同年龄层对脸部填充剂的需求不断增加预计将在预测期内推动市场成长。

美国脸部注射剂市场报告亮点

  • A型肉毒桿菌毒素可以治疗皱纹、鱼尾纹、嘴角等多种病症，因此在2023年赢得了超过55%的市场份额，并在产品类型中占据主导地位。
  • 由于越来越多的市场参与者专注于开发透明质酸填充剂，预计透明质酸细分市场将在预测期内实现最快的成长。对微创手术的需求不断增长和整容手术的激增正在推动市场成长。
  • 在美国脸部填充剂市场运作的市场参与者包括AbbVie, Inc.、REVANCE AESTHETICS、Merz North America, Inc.、Galderma Laboratories, LP、Suneva Medical Inc.、Cytophil, Inc.、Prollenium Medical Technologies等。
  • 2023年5月，Evolus宣布与Cimatese签订了五种正在开发的真皮填充剂的经销协议。这项倡议极大地帮助公司扩大了产品系列，并向成为多产品美容公司迈出了一步。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国脸部注射剂市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国脸部注射剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国脸部注射剂市场：产品预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 美国脸部注射剂市场展望（分产品）
  • 2018-2030年市场规模、预测及趋势分析
  • 胶原蛋白
  • A型肉毒桿菌毒素
  • HA
  • CaHA
  • PLLA
  • 其他的

第五章美国脸部注射剂市场：应用预估及趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 美国脸部注射剂市场展望（按应用）
  • 2018-2030年市场规模、预测及趋势分析
  • 轮廓矫正
  • 丰唇术
  • 拉皮
  • 痤疮疤痕治疗
  • 脂肪萎缩治疗
  • 其他的

第六章美国脸部注射剂市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国脸部注射剂市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 梅迪斯帕
  • 皮肤科诊所
  • 医院

第七章美国脸部注射剂市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 美国脸部注射剂市场按地区前景
  • 2018-2030年市场规模、预测及趋势分析
  • 西
  • 中西部
  • 东北
  • 西南
  • 东南

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • AbbVie, Inc.
    • REVANCE AESTHETICS
    • Merz North America, Inc.
    • Galderma Laboratories, LP
    • Suneva Medical Inc.
    • Cytophil, Inc
    • Prollenium Medical Technologies.
Product Code: GVR-4-68040-284-1

U.S. Facial Injectable Market Growth & Trends:

The U.S. facial injectable market is anticipated to reach USD 8.02 billion by 2030, exhibiting a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing acceptance of aesthetic procedures and the increasing geriatric population are some of the major factors driving the market growth.

The increasing geriatric population of the U.S. is increasing the demand for the development of minimally invasive surgical procedures. Facial injectable offer an alternative to several aesthetic surgical procedures. Moreover, these procedures offer several advantages, such as less pain, less trauma, lesser blood loss, and faster recovery. In addition, the increasing focus of market players on developing demand-specific solutions with lesser allergy risk significantly contributes to the market growth.

The increasing awareness about aesthetic procedures owing to the rising focus on facial appearance further drives the market growth. Moreover, the availability of facial injectable to address different demands of patients has increased their demand in different age groups as per their needs. For instance, according to the 2022 Plastic Surgery Statistics Report of The American Society of Plastic Surgeons, the number of neuromodulator injection procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 70% and 74% from 2019 simultaneously. Similarly, the number of HA filler procedures in the age group of 30 to 39 and 40 to 54 in 2022 has increased by 69% and 70% from 2019 simultaneously. This increasing demand for facial injectable in different age groups is expected to drive market growth over the forecast period.

U.S. Facial Injectable Market Report Highlights:

  • Botulinum toxin type A dominated the product segment with a share of over 55% share in 2023 owing to its wide treatment, such as wrinkles, glabellar lines, lateral canthus, and others.
  • The HA segment is expected to witness the fastest growth over the forecast period owing to the increasing focus of market players on developing hyaluronic fillers. The increasing demand for minimally invasive procedures and the surge in aesthetic procedures are driving the market growth.
  • Some of the market players operating in the U.S. facial injectable market include AbbVie, Inc., REVANCE AESTHETICS, Merz North America, Inc., Galderma Laboratories, L.P., Suneva Medical Inc., Cytophil, Inc, and Prollenium Medical Technologies.
  • In May 2023, Evolus, Inc. announced that the company had entered into an agreement with Symatese to be the distributor of five under-development derma fillers. This step significantly helped the company in expanding its product portfolio and taking a step towards becoming a multi-product aesthetic company.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Rising awareness of aesthetic procedures
      • 3.2.1.3. Increasing availability of innovative products
      • 3.2.1.4. Rise in the number of aesthetic procedures performed
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Threat of side effects
  • 3.3. U.S. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Facial Injectable Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Collagen & PMMA microspheres
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Botulinum toxin type A
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. HA
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. CaHA
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. PLLA
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Facial Injectable Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Facial line correction
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Lip augmentation
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Face lift
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Acne scar treatment
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Lipoatrophy treatment
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Facial Injectable Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Facial Injectable Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. MedSpa
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Dermatology clinics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospitals
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Facial Injectable Market: Region Estimates & Trend Analysis

  • 7.1. Regional Market Share, 2023 & 2030
  • 7.2. U.S. Facial Injectable Market by Region Outlook
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.3.1. West
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.3.2. Midwest
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Northeast
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Southwest
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.5. Southeast
      • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. AbbVie, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. REVANCE AESTHETICS
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merz North America, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Galderma Laboratories, L.P.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Suneva Medical Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Cytophil, Inc
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Prollenium Medical Technologies.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. facial injectable market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. facial injectable market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. facial injectable market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. facial injectable market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. facial injectable market: market outlook
  • Fig. 9 U.S. facial injectable competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. facial injectable market driver impact
  • Fig. 14 U.S. facial injectable market restraint impact
  • Fig. 15 U.S. facial injectable market: Product movement analysis
  • Fig. 16 U.S. facial injectable market: Product outlook and key takeaways
  • Fig. 17 Collagen & PMMA microspheres market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Botulinum toxin type A market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 HA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 CaHA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 PLLA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. facial injectable market: Application movement Analysis
  • Fig. 24 U.S. facial injectable market: Application outlook and key takeaways
  • Fig. 25 Facial line correction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Lip augmentation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Face lift market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Acne scar treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Lipoatrophy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. facial injectable market: End-use movement analysis
  • Fig. 32 U.S. facial injectable market: End-use outlook and key takeaways
  • Fig. 33 MedSpa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. facial injectable market: Regional movement analysis
  • Fig. 37 U.S. facial injectable market: Regional outlook and key takeaways
  • Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)